Fort Worth biotech company Eyevance Pharmaceuticals acquired in $225M deal
September 18, 2020 at 14:11 PM EDT
A Fort Worth-based biotech company focused on ophthalmic products has been acquired by the U.S. subsidiary of a Japanese pharmaceutical firm.
